Therapeutics Announces First Patient Enrolled in FDA-authorized Study Evaluating Low-Dose Psilocybin in Human Subjects with Demoralization by Diamond Therapeutics Inc.

Written By Anthony Pizzarelli

https://www.prnewswire.com/news-releases/diamond-therapeutics-announces-first-patient-enrolled-in-fda-authorized-study-evaluating-low-dose-psilocybin-in-human-subjects-with-demoralization-301959436.html

Anthony Pizzarelli
Previous

CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY
Next

Psychedelic Science: How Microdosing Magic Mushrooms Might Mend the Mind